Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma p
- PDF / 696,449 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 38 Downloads / 155 Views
and Other Interventional Techniques
Long‑term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low‑grade pseudomyxoma peritonei and multicystic mesothelioma Frederic Mercier1,2 · Guedj Jeremie1 · Mohammad Alyami1,3,4 · Vaudoyer Delphine1 · Kepenekian Vahan1,3 · Rousset Pascal3,5 · Isaac Sylvie6 · Passot Guillaume1,3 · Glehen Olivier1,3 Received: 16 November 2018 / Accepted: 23 November 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide long-term survival for low-grade pseudomyxoma peritonei (PMP) and multicystic peritoneal mesothelioma (MM). Feasibility of laparoscopic CRS-HIPEC has been reported for selected patients but data regarding long-term outcomes are missing to assess the oncological interest. This study aimed to report long-term outcomes for low-grade PMP and MM treated by laparoscopic approach. Methods From a prospectively maintained CRS-HIPEC database, all patients who underwent laparoscopic CRS-HIPEC with curative intent were analyzed. Selection criteria for laparoscopic approach were low-grade PMP or MM, with pathological confirmation prior to CRS-HIPEC, ASA 2, age
Data Loading...
